Active Ingredient History
Fish oil is oil derived from the tissues of oily fish. Fish oils contain the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), precursors of certain eicosanoids that are known to reduce inflammation in the body and improve hypertriglyceridemia. There has been a great deal of controversy in the 21st century about the role of fish oil in cardiovascular disease, with recent meta-analyses reaching different conclusions about its potential impact. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Cholestasis (approved 2016)
Nutritional and Metabolic Diseases (approved 2018)
Abdominal Neoplasms (Phase 4)
Acute Lung Injury (Phase 2)
Adiposity (Phase 2)
Aggression (Phase 2/Phase 3)
Aging (Phase 3)
Alcoholism (Phase 1)
Allergy and Immunology (Phase 2/Phase 3)
Alzheimer Disease (Phase 3)
Anemia, Sickle Cell (Phase 2)
Anorexia Nervosa (Phase 2)
Antisocial Personality Disorder (Phase 2/Phase 3)
Anxiety (Phase 2)
Arrhythmias, Cardiac (Phase 4)
Arthritis, Rheumatoid (Phase 3)
Asthma (Phase 3)
Atrial Fibrillation (Phase 4)
Atrial Flutter (Phase 4)
Bipolar Disorder (Phase 4)
Brain Concussion (Phase 1)
Breast Diseases (Phase 2)
Breast Neoplasms (Phase 4)
Bronchopulmonary Dysplasia (Phase 3)
Cachexia (Phase 4)
Cardiac Surgical Procedures (Phase 2/Phase 3)
Cardiovascular Diseases (Phase 3)
Child Development (Phase 3)
Cholangitis, Sclerosing (Phase 1)
Cholestasis (Phase 3)
Chylomicrons (Phase 2)
Cognition Disorders (Phase 2)
Cognitive Dysfunction (Early Phase 1)
Colitis (Phase 2)
Colonic Neoplasms (Phase 4)
Colorectal Neoplasms (Phase 2)
Coronary Artery Disease (Phase 4)
COVID-19 (Phase 2)
Critical Illness (Phase 4)
Crohn Disease (Phase 4)
Cystic Fibrosis (Phase 2)
Death, Sudden, Cardiac (Phase 1/Phase 2)
Dementia (Phase 1/Phase 2)
Depression (Phase 3)
Depressive Disorder, Major (Phase 2/Phase 3)
Diabetes, Gestational (Phase 2)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 2 (Phase 2)
Diabetic Neuropathies (Early Phase 1)
Dietary Supplements (Phase 1)
Drugs, Investigational (Phase 2)
Dyslipidemias (Phase 3)
Endometriosis (Phase 4)
Endothelial Cells (Phase 2)
Energy Transfer (Phase 4)
Enteral Nutrition (Phase 2/Phase 3)
Epilepsy (Phase 3)
Esophageal Atresia (Phase 2)
Esophageal Neoplasms (Phase 3)
Fatigue (Phase 2)
Fatty Acids (Phase 2/Phase 3)
Fatty Liver (Phase 3)
Feeding Behavior (Phase 2)
Gastrointestinal Absorption (Phase 4)
Gastrointestinal Diseases (Phase 2/Phase 3)
Gastroschisis (Phase 2)
General Surgery (Phase 4)
Genetic Diseases, X-Linked (Phase 2)
Gingivitis (Phase 2)
Health (Phase 4)
Healthy Volunteers (Phase 4)
Heart Disease Risk Factors (Phase 2)
Heart Failure (Phase 3)
Hematopoietic Stem Cell Transplantation (Phase 1)
HIV Infections (Phase 3)
Hypercholesterolemia (Phase 2)
Hyperlipidemias (Phase 4)
Hypertension (Phase 3)
Hypertension, Pregnancy-Induced (Phase 1)
Hypertriglyceridemia (Phase 2)
Infant, Premature, Diseases (Phase 2)
Inflammation (Phase 4)
Insulin Resistance (Phase 3)
Intestinal Atresia (Phase 2)
Intestinal Diseases (Phase 3)
Intestinal Neoplasms (Phase 4)
Kidney Diseases (Phase 3)
Kidney Failure, Chronic (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Lipid Metabolism Disorders (Phase 1)
Live Birth (Phase 2)
Liver Cirrhosis (Phase 3)
Liver Diseases (Phase 4)
Lung Neoplasms (Phase 3)
Lupus Erythematosus, Systemic (Phase 2)
Macula Lutea (Phase 4)
Macular Degeneration (Phase 1)
Metabolic Syndrome (Phase 3)
Metabolism (Phase 2)
Mucositis (Phase 2)
Multiple Sclerosis (Phase 2/Phase 3)
Multiple Sclerosis, Relapsing-Remitting (Phase 4)
Muscular Dystrophy, Duchenne (Phase 2)
Neonatology (Phase 3)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 3)
Neurodevelopmental Disorders (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 3)
Obesity (Phase 3)
Obesity, Abdominal (Early Phase 1)
Obstetric Labor, Premature (Phase 2)
Overweight (Phase 3)
Oxidative Stress (Phase 2/Phase 3)
Pancreatic Neoplasms (Phase 4)
Pancreatitis (Phase 2)
Parenteral Nutrition (Phase 4)
Parkinson Disease (Phase 1)
Periodontitis (Phase 2)
Peripheral Arterial Disease (Phase 2)
Physiology (Phase 1)
Polycystic Ovary Syndrome (Phase 4)
Pre-Eclampsia (Phase 1)
Pregnancy (Phase 3)
Pregnancy Complications (Phase 2)
Premature Birth (Phase 3)
Prostatic Neoplasms (Phase 2)
Protein Deficiency (Phase 4)
Proteomics (Phase 2)
Psychotic Disorders (Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Quality of Life (Phase 4)
Radiotherapy (Phase 4)
Respiratory Distress Syndrome (Phase 2)
Retinitis Pigmentosa (Phase 2)
Retinopathy of Prematurity (Phase 2)
Schizophrenia (Phase 4)
Sepsis (Phase 2)
Severe Acute Malnutrition (Phase 2)
Short Bowel Syndrome (Phase 2/Phase 3)
Smoking Cessation (Phase 2)
Stomach Neoplasms (Phase 4)
Tachycardia, Ventricular (Phase 1/Phase 2)
Thrombosis (Early Phase 1)
Tobacco Use Disorder (Phase 3)
Weight Loss (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
